SAB Biotherapeutics (SABS) Accounts Payables (2020 - 2026)
SAB Biotherapeutics (SABS) posted Accounts Payables of $7.21 million for Q2 2026, up 1.7% from $7.09 million a year earlier and up 33.8% from the prior quarter.
SAB Biotherapeutics (SABS) Accounts Payables (2020 - 2026) Analysis & Trends
At the end of FY2025, SAB Biotherapeutics' Accounts Payables came in at $6.58 million, up 20.3% from FY2024.
- Annual Accounts Payables shows a five-year compound annual growth rate of -2.3% (FY2020 to FY2025).
- In prior years, SAB Biotherapeutics' Accounts Payables was $5.47 million in FY2024 (-18.2%), $6.69 million in FY2023 (-32.5%), $9.92 million in FY2022 (-20.4%) and $12.46 million in FY2021 (+68.7%).
- The Q2 2026 figure stands as the highest quarterly Accounts Payables since Q1 2023.
- On a year-over-year basis, Accounts Payables increased in five of the last eight quarters, with growth averaging 9.9%.
- The strongest year-over-year quarter for Accounts Payables in the past five years was Q4 2021, with growth of 68.7%; the weakest was Q3 2023, with a decline of 48.2%.
- According to Business Quant data, Accounts Payables for the three prior quarters was $5.39 million (Q1 2026), $6.58 million (Q4 2025) and $6.85 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.58 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 429.50 Mn |
| 10 | SAB Biotherapeutics | 268.85 Mn | 268.85 Mn | - | 7.21 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.21 Mn |
| Mar 31, 2026 | 5.39 Mn |
| Dec 31, 2025 | 6.58 Mn |
| Sep 30, 2025 | 6.85 Mn |
| Jun 30, 2025 | 7.09 Mn |
| Mar 31, 2025 | 6.06 Mn |
| Dec 31, 2024 | 5.47 Mn |
| Sep 30, 2024 | 6.88 Mn |
| Jun 30, 2024 | 5.05 Mn |
| Mar 31, 2024 | 5.17 Mn |
| Dec 31, 2023 | 6.69 Mn |
| Sep 30, 2023 | 5.30 Mn |
| Jun 30, 2023 | 5.93 Mn |
| Mar 31, 2023 | 8.19 Mn |
| Dec 31, 2022 | 9.92 Mn |
| Sep 30, 2022 | 10.24 Mn |
| Jun 30, 2022 | 9.86 Mn |
| Mar 31, 2022 | 11.86 Mn |
| Dec 31, 2021 | 12.46 Mn |
| Dec 31, 2020 | 7.38 Mn |
SAB Biotherapeutics Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=SABS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "SABS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=SABS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();